Skip to content
TESCT — Trans European Stem Cell Therapy Society
Portrait of Dr. Marco Traub

TESCT — Berne, Switzerland · London, United Kingdom

marco.traub@tesct.org

Executive team

Dr. Marco Traub

CEO & Founder

  • PhD
  • Founder, TESCT (2005)
  • EU Commission Expert

Dr. Marco Traub has gained considerable experience in a number of research, management and educational roles over the past 20 years. He is the founder of the Trans European Stem Cell Therapy Consortium (TESCT) in 2005 and acts since as Chair of the TESCT consortium and as EU-Commission Expert in FP7 and the Innovative Medicines Initiative (IMI 1+2) 2018, which is a public private partnership between the European Commission (FP6/FP7/Horizon 2020, Health and Life Sciences) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) and COST framework for Switzerland. While in Switzerland and the UK, he specialised in biotechnology, with a focus on PCR technology and peptide synthesis and their GMP production.

In the same period he was Assistant Professor at the Medical School, University of Kansas City, involved in research projects and teaching on neuro-anatomy and opiate receptor pharmacology as well as in molecular medicine. His current technical expertise is focused on stem cell isolation and expansion and banking and iPSC with gene editing. In addition, he has participated successfully as project co-ordinator in grant applications and (EU) funded projects and has received Exploratory and Research awards from the EU-Commission and the Swiss Government for the following selected projects: “Development of Ultrasensitive Diagnostic Assays for the Detection of Genetic Disorders, Infections and for Monitoring the Therapeutic Success following Gene Therapy” and “Establishment of novel Targets for Risk Assessment and monitoring of Xenogeneic Infections in the Course of Animal to Human Transplantation”.

He acts as invited speaker and adviser to the World Congress for Freedom of Scientific Research and the “Associazione Luca Coscioni”, in cooperation with the Permanent Mission of Italy to the United Nations and International Organizations in Geneva.

Areas of work

  • Regenerative medicine
  • Stem cell banking
  • Cell therapy regulation